Publications

Results:
Category: Diane DiEuliis

April 27, 2020

Beyond 1918: Bringing Pandemic Response into the Present, and Future

The current pandemic gives us an opportunity to envision new tools, methods, and response policies that leverage emerging technologies, which, if adopted and prudently employed, would enable capability to far better predict, prepare, if not prevent the “next” biosecurity war, and not merely repeat the errors of the “last”. 

April 13, 2020

Ready or Not: Regaining Military Readiness during COVID19

In the latest Institute for National Strategic Studies "Strategic Insight," Dr. Diane DiEuliis and Dr. Laura Junor examine what the Department of Defense needs to maintain force readiness during the coronavirus (COVID-19) pandemic. Force readiness and management will be improved by rapidly deploying a point of care serological test to all in the U.S. military.

April 2, 2020

Modernizing biotechnology for the fight against COVID-19 and the future of pandemic response

Alexander Titus, Michelle Rozo, and Diane DiEuliis provide some perspective on the importance of using advanced biotechnology capabilities during the global pandemic.

Jan. 22, 2020

Redefining Neuroweapons: Emerging Capabilities in Neuroscience and Neurotechnology

As global conflicts assume increasingly asymmetric and “gray zone” forms, the ability to employ current and newly developing techniques and tools of neurocognitive science to manipulate human thought and behavior must be viewed as a present and increasing challenge. DeFranco, DiEuliis, and Giordano examine how developments in neuroscience and technology (neuroS/T) make the brain sciences of growing value for operational use in warfare, intelligence, and national security…

Dec. 2, 2019

Synthetic Biology Industry Practices and Opportunities for Biosecurity and Potential Roles for the U.S. Government

This report summarizes discussions with industry representatives about the current and future structure of the synthetic biology industry, perspectives on potential misuse and vulnerabilities of synthetic biology tools and capabilities, and business practices to prevent misuse of tools and to protect industry assets.

Aug. 22, 2019

Biospecimens and the Information Landscape for Biodefense

As genomic sequencing and synthesis tools continue to grow, the genomic information associated with biospecimens is expanding rapidly; the convergence of the physical and digital worlds has yet unexamined impacts to our traditional biodefense frameworks.

Dec. 3, 2018

Biotechnology for the Battlefield: In Need of a Strategy

In her article, published on War on the Rocks, CSWMD Senior Research Fellow Dr. Diane DiEuliis discusses the need for a more cohesive strategy to harness the potential uses of biotechnology on the battlefield.

April 4, 2018

Biodata Risks and Synthetic Biology: A Critical Juncture

Intrinsic to growing ability to apply classical engineering to biological systems is the mounting ‘digitization of biology’, as the genetic code and its related metadata (including translated proteins, associated functions, herein referred to as “biodata”) are amassed in order to engineer biology for specific purposes. There are three unique risks categories associated with the digitization of biology: 1) pathogen risks; 2) manufacturing risks, and 3) risks to individual privacy that can allow human harms.

Nov. 3, 2017

Biosecurity Implications for the Synthesis of Horsepox, an Orthopoxvirus

This article examines the biosecurity and biodefense implications resulting from the recent creation of horsepox virus, a noncirculating (extinct) species of orthopoxvirus. Here we examine the technical aspects of the horsepox virus synthesis and conclude that orthopox synthesis experiments currently remain technically challenging—and will continue to be so, even once this work is published in the scientific literature.

Oct. 3, 2017

Options for Synthetic DNA Order Screening, Revisited

DNA synthesis is a valuable research tool in the design of new biological products for medicine and manufacturing, and the ability to chemically synthesize long tracts of DNA has allowed for the development of influenza vaccines and diagnostic tests.